SOURCE: ZELTIQ Aesthetics, Inc.

ZELTIQ Aesthetics, Inc.

March 03, 2016 09:00 ET

ZELTIQ® Launches 3-in-1 CoolAdvantage™ Applicator for the CoolSculpting® System at American Academy of Dermatology Annual Meeting

New Applicator Line Reduces CoolSculpting® Treatment Time Nearly in Half

PLEASANTON, CA--(Marketwired - March 03, 2016) -  ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the launch of a new family of applicators called CoolAdvantage™ at the American Academy of Dermatology (AAD) Annual Meeting in Washington, D.C., March 4-8, 2016. The CoolAdvantage applicator delivers the proprietary CoolSculpting® cooling technology at a lower temperature, reducing treatment time nearly in half, and features an adaptable 3-in-1 configuration and enhanced cup design.

By changing the shape of the applicator cup to increase direct tissue contact and lowering the temperature, the CoolAdvantage applicator delivers safe and efficacious results in just 35 minutes, shortening CoolSculpting treatment time by nearly 50 percent. A clinical study compared the CoolAdvantage enhancements to the commercially available CoolCore™ applicator, demonstrating equivalent fat layer reduction measured by ultrasound and blinded photographic review. The new applicator cup shape led to a 45 percent increase in comfort during the treatment -- already considered very tolerable by most patients. Eighty-five percent of the study subjects preferred the CoolAdvantage treatment due to its decreased treatment time and increased comfort. The full CoolAdvantage clinical study results will be presented by the Principal Investigator, Suzanne Kilmer, M.D., at the American Society for Laser Medicine and Surgery (ASLMS) Annual Conference in Boston, MA on April 2, 2016.

"I am proud to have contributed to ZELTIQ's collection of clinical data, most recently with the CoolAdvantage applicator clinical study," said Suzanne Kilmer, M.D., Founding Director of the Laser and Skin Surgery Center of Northern California in Sacramento. "The CoolSculpting procedure has stood the test of time with more than 10 years of safety and efficacy data, over 60 published clinical publications and millions of treatments performed worldwide. For these reasons and more, the CoolSculpting procedure has established itself as the gold standard in non-invasive fat reduction." 

CoolAdvantage is the third CoolSculpting applicator to utilize new treatment parameters based on clearance the company received last year from the Food and Drug Administration (FDA) to perform the CoolSculpting procedure at lower temperatures for shorter treatment times. It comes with three interchangeable contours, creating three distinct applicators to address multiple treatment areas on the patient:

  • CoolFit Advantage™ is ideal for vertical areas of fat such as the inner thigh.
  • CoolCore Advantage™ best matches the contours of the abdomen.
  • CoolCurve+ Advantage™ is the applicator of choice for flanks.

"Patient and provider satisfaction is what drives our commitment to innovation," explained Mark Foley, President and Chief Executive Officer at ZELTIQ. "For our CoolSculpting patients, this means delivering better outcomes than ever before based on shorter treatment times and increased comfort. For our CoolSculpting providers, this means continuing to advance the original system by offering a single new applicator with multiple treatment opportunities and the ability to dramatically improve patient throughput and increase practice revenues."

To learn more about the CoolSculpting procedure and the CoolAdvantage applicator, visit ZELTIQ at AAD booth #3545 in the Walter E. Washington Convention Center during exhibit hours 10 a.m. to 5 p.m. on March 4-5, and 10 a.m. to 3 p.m. on March 6.

The CoolSculpting procedure is FDA-cleared. It is available in the United States for the non-invasive treatment of visible fat bulges in the submental area, thigh, abdomen and flank. In other international markets, it is approved for general non-invasive fat reduction. The CoolSculpting procedure results in a noticeable and measurable reduction of fat in the treated areas, and the treated cells fat are gone for good. Most patients can start to see results as soon as three weeks following treatment, with the most dramatic results occurring over a period of one to three months. Every patient is unique, so patients are encouraged to talk to their physicians about a customized treatment plan as part of the initial consultation. Additional treatments in the same or multiple areas may enhance the desired aesthetic effect. 

The CoolSculpting procedure is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at www.coolsculpting.com

About the CoolSculpting ® Procedure

The CoolSculpting procedure is a non-surgical, clinically proven procedure that selectively reduces unwanted fat using a patented cooling technology. The CoolSculpting procedure is cleared by the FDA. The CoolSculpting procedure works by gently cooling targeted fat cells in the body to induce a natural, controlled elimination of fat cell without affecting surrounding tissue, and the treated fat cells are gone for good. Millions of CoolSculpting treatments have been performed by nearly 4,000 CoolSculpting systems in over 70 countries. Market research indicates up to a 95 percent customer satisfaction rate with the CoolSculpting procedure. The CoolSculpting procedure is available through an elite network of CoolSculpting Centers worldwide. Dermatologists, plastic surgeons and leading aesthetic specialists that offer CoolSculpting can be found at www.coolsculpting.com.

Be sure to follow CoolSculpting on Facebook, Twitter, Pinterest and YouTube.

About ZELTIQ ® Aesthetics, Inc.

ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting system, is designed to selectively reduce unwanted fat that may not respond to diet or exercise. The CoolSculpting procedure is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed the CoolSculpting procedure to safely, noticeably, and measurably reduce the fat layer.

Image Available: http://www.marketwire.com/library/MwGo/2016/3/3/11G085727/Images/CoolAdvantage-Base-Contours-leftangle-a4c36b383eb0a6cf852bd06a0c3e73f9.jpg